3 results
Approved WMOCompleted
The primary efficacy objective is to evaluate whether LMWH is superior to VKAs in the long-term treatment of symptomatic VTE in cancer patients who completed 6 to 12 months of anticoagulant treatment. Two aspects are important: the efficacy with…
Approved WMOCompleted
The primary goal of this study is to evaluate the effect of varying stimulation parameters (inter-phase gap, phase duration, en inter-pulse interval) on the nerve and brainstem response and to correlate this to speech perception performance with the…
Approved WMORecruiting
Our objective is to study if reduced anticoagulation targets diminish bleeding complications without an increase in thromboembolic complications or a negative impact on outcome.